Pediatr Nephrol (2008) 23:1257–1267 36. Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC (2004) Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 66:1403–1416 37. Brewster UC, Perazella MA (2004) The renin-angiotensin- aldosterone system and the kidney: Effects on kidney disease. Am J Med 116:263–272 38. Hollenberg NK (1999) Pharmacologic interruption of the renin- angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition. J Am Soc Nephrol 10 (Suppl 11):S239–S242 39. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL (2004) Intrarenal Renin- Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15:1805–1815 40. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM (1991) Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847–858 41. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1996) Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885–892 42. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM (1992) Renal injury from angiotensin II- mediated hypertension. Hypertension 19:464–474 1267 43. Minutolo R, Balletta MM, Catapano F, Chiodini P, Tirino G, Zamboli P, Fuiano G, Russo D, Marotta P, Iodice C, Conte G, De Nicola L (2006) Mesangial hypercellularity predicts anti- proteinuric response to dual blockade of RAS in primary glomerulonephritis. Kidney Int 70:1170–1176 44. Hernandez E, Toledo T, Alamo C, Mon C, Rodicio JL, Praga M (1997) Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am J Kidney Dis 30:397–403 45. Kawasaki Y, Suzuki J, Nozawa R, Sakai N, Tannji M, Isome M, Suzuki H, Nozawa Y (2004) FB21, a monoclonal antibody that reacts with a sialic-acid-dependent carbohydrate epitope, is a marker for glomerular endothelial cell injury. Am J Kidney Dis 44:239–249 46. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82:12–22 47. Wolf G, Ziyadeh FN, Zahner G, Stahl RA (1996) Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hyperten- sion 27:897–905 48. Cresci B, Giannini S, Pala L, Mavilia C, Manuelli C, Cappugi P, Maggi E, Rotella CM (2003) AT1 and AT2 receptors in human glomerular endothelial cells at different passages. Microvasc Res 66:22–29 49. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y (1990) IgA nephropathy in Japanese children and adults: a compar- ative study of clinicopathological features. Am J Nephrol 10:191–197